Sanofi will work with Google's life sciences team to collect, analyze and understand information impacting diabetes, which is expected to affect 592 million by 2035, according to the International Diabetes Federation.
Note
Google's life sciences unit is already collaborating with Swiss drugmaker Novartis AG to develop contact lenses to help diabetics track blood glucose levels or restore the eye's ability to focus.
Google has also tied up with DexCom Inc, a maker of continuous glucose-monitoring (CGM) devices, to develop a CGM device the size of a band-aid that can be worn on the skin.
Google is also working with Biogen Inc to study the progression of multiple sclerosis.
No comments:
Post a Comment